Shaf Keshavjee and UHN have set up several strategic partnerships, and SQI is among them.
Both UHN & SQI have recieved government support to assist in getting these important products to market. SQI has a valuable role to play in scoring of organs.
TOR-dx and RALI products are poised to impact patient care significantly.
The heaviest of lifting is behind them.
Hero's continue to support Shaf's vision.
Organ repair centers are already making progress and continued SQI integration is key for all involved.
While all pages of deck are relevant, be sure to digest pages 9, 10, & 21
The TOR-dx is among the most exciting of products with FDA on the horizon, with hundreds of millions in revenue to follow. This is a proprietary product and Shaf is guiding protocols around the globe.
RALI products also represent huge volume and present significant partnering opportunities. $B+
Two decades of research and development now positioned for regulatory and deployment.
SQI-Diagnostics-Inc-Corporate-Information-FEB2023.pdf